secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001601830-23-000075
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Recursion registers 3.2M shares of Class A common stock for resale by Tempus Labs
--------------------------------------------------------------------------------

- 3,225,902 shares registered for resale by Tempus Labs as payment for initial license fee under Master Agreement.
- Prospectus supplement filed under effective shelf registration statement (Form S-3ASR) on December 15, 2023.
- Shares were originally issued to Tempus in November 2023 per the Master Agreement described in prior Form 8-K.
- Resale offering is exempt from registration under the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183023000075/0001601830-23-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183023000075/rxrx-20231215.htm
  HTML page:      https://secwatch.observer/filing/0001601830-23-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer